Literature DB >> 32444178

Chromophobe renal cell carcinoma: New genetic and metabolic insights.

Long Zhang1, Elizabeth P Henske2.   

Abstract

Chromophobe renal cell carcinoma (chRCC) represents 5% of all RCC. ChRCC appears to arise from the distal nephron, in contrast to clear cell RCC that arises from the proximal nephron. ChRCC is distinctive because the tumor cells contain abundant abnormal mitochondria, and frequently have loss of one copy of multiple chromosomes, with a low rate of somatic mutations. Here, we focus on recent discoveries related to genetic and metabolic factors that may promote the progression of chRCC and summarize how these findings may relate to the prognosis and treatment of chRCC.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromophobe renal cell carcinoma; GGT1; Metabolic reprogramming; PTEN

Mesh:

Year:  2020        PMID: 32444178     DOI: 10.1016/j.urolonc.2020.04.035

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  2 in total

1.  Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.

Authors:  Khaled Bin Satter; Zach Ramsey; Paul M H Tran; Diane Hopkins; Gregory Bearden; Katherine P Richardson; Martha K Terris; Natasha M Savage; Sravan K Kavuri; Sharad Purohit
Journal:  Cancers (Basel)       Date:  2022-07-01       Impact factor: 6.575

2.  Oncocytoma-Related Gene Signature to Differentiate Chromophobe Renal Cancer and Oncocytoma Using Machine Learning.

Authors:  Khaled Bin Satter; Paul Minh Huy Tran; Lynn Kim Hoang Tran; Zach Ramsey; Katheine Pinkerton; Shan Bai; Natasha M Savage; Sravan Kavuri; Martha K Terris; Jin-Xiong She; Sharad Purohit
Journal:  Cells       Date:  2022-01-15       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.